Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer

Author: Dowlati Afshin   Chapman Robert   Subbiah Shanmuga   Fu Pingfu   Ness Anne   Cortas Tania   Patrick Lauren   Reynolds Sherrie   Xu Natalie   Levitan Nathan   Ivy Percy   Remick Scot  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.23, Iss.6, 2005-12, pp. : 563-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content